China Chengdu-based Hanchen Scientific closes more than 300 million yuan ($41 million) Series B+ financing, making the total amount of series B financing more than 500 million yuan ($68 million).
This round of financing was jointly led by Lake Bleu Capital and Guotai Junan Innovation Investment, followed by Delton Investment, Eightfold Venture Partners and Chengdu Bio-town Fund, with additional investment from old shareholders Legend Capital and LYFE Capital.
This round of financing will be mainly used for the development of new products in the field of life sciences instrument and IVDs equipment, marketing, overseas business development and talents acquisition.
Founded in 2016, Hanchen Scientific focuses on life sciences intelligent automation, and is a leading domestic enterprise in the field of intelligent automation for scientific research and molecular diagnosis.
The Post is Available in: English – 简体中文